Viruses 2010, 2(4), 1002-1007; doi:10.3390/v2041002
Editorial

Novel Viral Vector Systems for Gene Therapy

Quantitative Biosciences Institute, Department of Chemical Engineering, University of California, Berkeley, CA 94720, USA
Received: 13 April 2010; Accepted: 13 April 2010 / Published: 14 April 2010
(This article belongs to the Special Issue Novel Viral Vector Systems for Gene Therapy)
PDF Full-text Download PDF Full-Text [36 KB, uploaded 14 April 2010 11:34 CEST]
Abstract: Over the last three decades, interest in the field of gene therapy seems to have fluctuated between hot and cold. Encouraging pre-clinical and clinical data has demonstrated the potential of genetic therapies and yet setbacks in clinical trials have cast doubts in some minds over the clinical future of gene therapy [1-3]. In the last two years, a number of studies have demonstrated therapeutic benefits in clinical trials aimed towards specific monogenetic disorders [4-6], and this has brought renewed optimism to the field. [...]

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Stone, D. Novel Viral Vector Systems for Gene Therapy. Viruses 2010, 2, 1002-1007.

AMA Style

Stone D. Novel Viral Vector Systems for Gene Therapy. Viruses. 2010; 2(4):1002-1007.

Chicago/Turabian Style

Stone, Daniel. 2010. "Novel Viral Vector Systems for Gene Therapy." Viruses 2, no. 4: 1002-1007.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert